Breakthrough Xerogel dressing promises rapid blood clotting for trauma care

New Delhi: In a promising advancement for trauma and surgical care, researchers at the Agharkar Research Institute (ARI), an autonomous institute under the Department of Science and Technology (DST) in Pune have developed a highly porous xerogel dressing that significantly accelerates blood clotting, potentially saving countless lives by addressing uncontrolled hemorrhage more effectively. This innovation incorporates silica nanoparticles (SiNPs) and calcium, which are known to enhance blood clotting. 

Uncontrolled hemorrhage remains one of the leading causes of traumatic deaths, accounting for more than 40% of trauma fatalities due to severe blood loss. Traditional methods, such as gauze or the body’s natural clotting mechanisms, often prove inadequate in stopping severe hemorrhage, creating an urgent need for improved hemostatic materials.

The Xerogel dressing presents a groundbreaking solution. It increases the blood clotting index by 13-fold compared to commercial dressings. The porous structure, with multiple pores around 30 micrometers in size, enhances the absorbance capacity of the dressing, facilitating rapid blood absorption and clot formation.

Platelets, a crucial component in the blood clotting process, are activated by the xerogel dressing. The dressing promotes platelet aggregation through well-formed pseudopodia in the activated platelets, leading to effective blood clotting. Additionally, it enhances calcium release and extrusion, a critical factor in platelet function.

The study, published in the Journal of Applied Polymer Science, highlights the role of intracellular molecular mechanisms, including the activation of the protease-activated receptor gene (PAR1 gene) in platelet membranes. This activation is vital for thrombin signaling and platelet aggregation, contributing to the hemostatic efficiency of the xerogel composite.

The researchers believe that this innovative xerogel dressing could provide a potential hemostatic solution to reduce blood loss, disability, and mortality during surgical and trauma care. By offering a faster and more efficient clotting mechanism, this dressing could revolutionize emergency and medical response to severe injuries and surgeries, offering new hope in critical care scenarios.